

Classification: GLP-1/Glucagon Receptor Dual Agonist
Active substance: Survodutide
Manufacturer: Dragon Pharma
Form/Strength: Lyophilized Powder, 10 mg / vial
Pack size: 2 mL Vial
Route: Subcutaneous Injection
Lab Test: View Result
For bodybuilders and fitness enthusiasts pushing the limits of leanness, traditional diet and cardio often hit a wall. Welcome to the cutting edge of metabolic science: Dragon Pharma Survodutide. This is not just another appetite suppressant; it's a potent dual-agonist peptide that targets two key metabolic pathways simultaneously for unprecedented fat loss results. When you buy Survodutide online, you are investing in one of the most powerful tools available for shredding stubborn body fat and achieving that coveted, stage-ready physique.
Survodutide (also known as BI 456906) is a novel peptide that acts as a dual agonist for the glucagon-like peptide-1 (GLP-1) and glucagon receptors. This means it mimics the actions of both natural hormones. GLP-1 slows gastric emptying, reduces appetite, and promotes insulin secretion. Glucagon increases energy expenditure by stimulating the liver to break down fat and glycogen. Together, this dual action creates a powerful "calories in vs. calories out" advantage: you eat less and burn more. The National Institutes of Health published a study highlighting the significant weight loss efficacy of this GLP-1/glucagon dual agonist mechanism.
Dragon Pharma Survodutide offers a profound set of benefits specifically targeted for cutting phases:
Dragon Pharma Survodutide comes as a 10mg lyophilized powder that must be reconstituted with Bacteriostatic Water. Dosing must be approached carefully to manage potential side effects.
Always consult with a healthcare professional before use and start low to assess your individual tolerance.
Survodutide is the centerpiece of a cutting cycle. It is perfectly complemented by other compounds that preserve muscle mass and enhance definition. A strategic Dragon Pharma stack might include:
The side effects of Survodutide are primarily related to its gastrointestinal mechanisms and are usually dose-dependent and transient. They often subside after a few weeks of continued use. The most common include:
Staying hydrated and starting with a low dose can help mitigate these effects. The mechanism of action of the GLP-1/glucagon dual agonist Survodutide is well-documented in leading endocrine journals.
With the high demand for peptides, under-dosed and impure products are rampant. Dragon Pharma eliminates this risk. Each batch is independently verified for accuracy and purity. Our recent lab test confirms this vial contains 9.68 mg of 99.704% pure Survodutide, ensuring you receive a potent and effective product that delivers real, measurable results.
Date: 2024-09-13
Result: 9.68 mg; Purity: 99.704%
While all are GLP-1 receptor agonists, Survodutide has a key difference: it's a dual agonist for both GLP-1 and glucagon receptors. Semaglutide (e.g., Wegovy, Ozempic) primarily targets GLP-1. Tirzepatide (e.g., Mounjaro) is a dual GLP-1 and GIP agonist. Survodutide's glucagon component is theorized to provide a stronger effect on increasing energy expenditure and fat burning, potentially making it more potent for weight loss.
Use Bacteriostatic Water for reconstitution. Gently inject the water into the 10mg vial, aiming the stream against the glass wall. Roll the vial gently between your hands until the powder is completely dissolved. Do not shake, as aggressive shaking can damage the peptide structure. Once reconstituted, store the vial in the refrigerator.
It is not recommended. Survodutide is explicitly designed to create a caloric deficit by suppressing appetite and increasing calorie burning. This is counterproductive to the goal of a bulking cycle, which requires a calorie surplus to build muscle. Survodutide is best reserved for cutting and shredding phases.
The best strategy is to manage side effects by titrating your dose. If you experience strong nausea or GI distress, do not increase your dose further. You can even consider lowering the dose until your body adjusts. Staying hydrated and eating bland, small meals can help. If severe side effects persist, discontinue use.
Appetite suppression is often noticeable within the first 1-2 days of the initial dose. Significant weight loss results typically become evident within the first 4-8 weeks of consistent use, especially as you titrate up to an effective maintenance dose. Results are maximized when combined with a calorie-controlled diet and regular exercise.
Please log in to write Survodutide 10 mg review.
Classification: Growth Hormone Secretagogue (GHRP)
Active substance: Ipamorelin
Manufacturer: Dragon Pharma
Form/Strength: Lyophilized Powder, 5 mg/vial
Pack size: 2 mL Vial
Route: Subcutaneous (SC) Injection
Lab Test: View Result
Classification: Synthetic Melanocortin Peptide
Active substance: Melanotan II
Manufacturer: Dragon Pharma
Form/Strength: Lyophilized Powder / 10 mg per vial
Pack size: 2 mL Vial
Route: Subcutaneous Injection (Reconstituted with Bacteriostatic Water)
Lab Test: View Result
Classification: Metabolic Peptide (GLP-1/GIP Receptor Agonist)
Active substance: Tirzepatide
Manufacturer: Dragon Pharma
Form/Strength: Lyophilized Powder, 5 mg/vial
Pack size: 2 mL Vial
Route: Subcutaneous Injection (Reconstitution Required)
Lab Test: View Result
Classification: Nootropic Peptide
Active substance: Semax
Manufacturer: Dragon Pharma
Form/Strength: Lyophilized Powder / 5 mg per 2 mL vial
Pack size: 1 Vial
Route: Intranasal or Subcutaneous
Lab Test: View Result
Classification: Research Peptide (Body Protecting Compound)
Active substance: BPC 157 (Pentadecapeptide)
Manufacturer: Dragon Pharma
Form/Strength: Lyophilized Powder, 5 mg/vial
Pack size: 2 mL Vial (Requires Reconstitution)
Route: Subcutaneous (SubQ) or Near Injury
Lab Test: View Result